혈액투석 환자의 빈혈 치료에 있어서 고용량의 피하 Recombinant Human Erythropoietin 의 유효성 및 안전성 평가 : 다기관 무작위 배정, 공개, 제 3상 연구

초록

Anemia can be effectively treated with erythropoietin. This study aimed to evaluate the safety and effectiveness of high dose erythropoietin in hemodialysis patients. High dose once weekly or fortnightlu SC administration of recombinant human erythropoietin os as safe and effective as two or three times weekly IV or SC administration of the sane total dose in maintaining hemoglobin levels in hemodialysis patients.